If the symptoms resolve, you've found your answer
So powerful that many people simply stop eating enough
Astrup A, Carraro R, Finer N, Harper A, Kunesova M, Lean ME et al (2012) Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide
Low molecular weight hydroxyethyl chitosan-prednisolone conjugate for renal targeting therapy: synthesis, characterization and in vivo studies
This increase in visceral abdominal fat is linked with increased inflammation and free fatty acids that impair metabolic function, and is also linked to a higher risk of cardiovascular disease and metabolic syndrome
Later that year, FDA and industry groups hosted workshops on AI in pharmaceutical production